Skip to main content

Breast Cancer

Fairouz L. Chibane, MD and Alicia H. Vinyard, DO Reviewed 06/2019
 


BASICS

DESCRIPTION

  • Malignant neoplasm of cells native to the breast—epithelial, glandular, or stroma

  • Types: ductal carcinoma in situ (DCIS), infiltrating ductal carcinoma, infiltrating lobular carcinoma...

DIAGNOSIS

HISTORY

  • Painless lump in breast or axilla, breast pain, heaviness

  • Swelling, thickening, redness, or dimpling of the skin (sign of advanced BC)

  • Nipple discharge (bloody), erosion, or retraction

  • A...

TREATMENT

MEDICATION

  • Neoadjuvant chemotherapy: Premenopausal women should be counseled on potential effect of chemotherapy on fertility; refer to fertility expert.

    • Locally advanced (positive lymph nodes...

ONGOING CARE

FOLLOW-UP RECOMMENDATIONS

  • Every 4 to 6 months for 5 years and then annually

  • No evidence to support the use of routine CBC, LFTs, “tumor markers,” bone scan, CXR, liver US, CT scans, MRI, PE...

REFERENCES

1
American Cancer Society. Breast Cancer Facts & Figures 2017–2018. Atlanta, GA: American Cancer Society; 2017. http://www.cancer.org. Accessed August 21, 2018. http://www.cancer.org. Ac...

ADDITIONAL READING

  • Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial...

CODES

ICD10

  • C50.919 Malignant neoplasm of unsp site of unspecified female breast

  • D05.90 Unspecified type of carcinoma in situ of unspecified breast

  • Z12.31 Encntr screen mammogram for malignant neoplasm o...

CLINICAL PEARLS

  • BC is most common CA death in U.S. women; lifetime risk of 1 in 8

  • High alcohol use, high body mass index (BMI), and physical inactivity are modifiable risk factors.

  • Pursue/refer all abno...

Subscribe to Access Full Content

Sign Up for a 10-Day Free Trial

Sign up for a 10-day FREE Trial now and receive full access to all content.

 
×